These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30457982)

  • 1. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.
    Dong S; Harrington BK; Hu EY; Greene JT; Lehman AM; Tran M; Wasmuth RL; Long M; Muthusamy N; Brown JR; Johnson AJ; Byrd JC
    J Clin Invest; 2019 Jan; 129(1):122-136. PubMed ID: 30457982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.
    Aragoneses-Fenoll L; Ojeda G; Montes-Casado M; Acosta-Ampudia Y; Dianzani U; Portolés P; Rojo JM
    Front Immunol; 2018; 9():332. PubMed ID: 29535720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells.
    Liu D; Zhang T; Marshall AJ; Okkenhaug K; Vanhaesebroeck B; Uzonna JE
    J Immunol; 2009 Aug; 183(3):1921-33. PubMed ID: 19596993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of p110δ isoform of the phosphoinositide 3 kinase leads to enhanced resistance to Leishmania donovani.
    Khadem F; Mou Z; Liu D; Varikuti S; Satoskar A; Uzonna JE
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2951. PubMed ID: 24945303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice.
    Khadem F; Gao X; Mou Z; Jia P; Movassagh H; Onyilagha C; Gounni AS; Wright MC; Uzonna JE
    Hepatology; 2016 Feb; 63(2):620-32. PubMed ID: 26289140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K p110δ is expressed by gp38(-)CD31(+) and gp38(+)CD31(+) spleen stromal cells and regulates their CCL19, CCL21, and LTβR mRNA levels.
    Zotes TM; Spada R; Mulens V; Pérez-Yagüe S; Sorzano CO; Okkenhaug K; Carrera AC; Barber DF
    PLoS One; 2013; 8(8):e72960. PubMed ID: 24009720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110δ.
    Uno JK; Rao KN; Matsuoka K; Sheikh SZ; Kobayashi T; Li F; Steinbach EC; Sepulveda AR; Vanhaesebroeck B; Sartor RB; Plevy SE
    Gastroenterology; 2010 Nov; 139(5):1642-53, 1653.e1-6. PubMed ID: 20637203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function.
    Chellappa S; Kushekhar K; Munthe LA; Tjønnfjord GE; Aandahl EM; Okkenhaug K; Taskén K
    J Immunol; 2019 Mar; 202(5):1397-1405. PubMed ID: 30692213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.
    Hanna BS; Roessner PM; Scheffold A; Jebaraj BMC; Demerdash Y; Öztürk S; Lichter P; Stilgenbauer S; Seiffert M
    Leukemia; 2019 Jun; 33(6):1427-1438. PubMed ID: 30573773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury.
    Bilancio A; Rinaldi B; Oliviero MA; Donniacuo M; Monti MG; Boscaino A; Marino I; Friedman L; Rossi F; Vanhaesebroeck B; Migliaccio A
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28851839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
    Reinart N; Nguyen PH; Boucas J; Rosen N; Kvasnicka HM; Heukamp L; Rudolph C; Ristovska V; Velmans T; Mueller C; Reiners KS; von Strandmann EP; Krause G; Montesinos-Rongen M; Schlegelberger B; Herling M; Hallek M; Fingerle-Rowson G
    Blood; 2013 Jan; 121(5):812-21. PubMed ID: 23118218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets.
    Liu D; Uzonna JE
    J Immunol; 2010 Mar; 184(6):3098-105. PubMed ID: 20154209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8
    Spinelli L; Marchingo JM; Nomura A; Damasio MP; Cantrell DA
    Front Immunol; 2021; 12():691997. PubMed ID: 34220851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Phosphatidylinositol 3-Kinase δ Signaling Leads to Diminished Numbers of Regulatory T Cells and Increased Neutrophil Activity Resulting in Mortality Due to Endotoxic Shock.
    Okeke EB; Mou Z; Onyilagha N; Jia P; Gounni AS; Uzonna JE
    J Immunol; 2017 Aug; 199(3):1086-1095. PubMed ID: 28659355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells.
    Okkenhaug K; Patton DT; Bilancio A; Garçon F; Rowan WC; Vanhaesebroeck B
    J Immunol; 2006 Oct; 177(8):5122-8. PubMed ID: 17015696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse.
    Hu X; Li J; Zhang Q; Zheng L; Wang G; Zhang X; Zhang J; Gu Q; Ye Y; Guo SW; Yang X; Wang L
    Sci Rep; 2016 Jun; 6():28201. PubMed ID: 27306493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.
    Ali K; Soond DR; Pineiro R; Hagemann T; Pearce W; Lim EL; Bouabe H; Scudamore CL; Hancox T; Maecker H; Friedman L; Turner M; Okkenhaug K; Vanhaesebroeck B
    Nature; 2014 Jun; 510(7505):407-411. PubMed ID: 24919154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of PI3Kδ induces vascular injury and promotes aneurysm development by upregulating the AP-1/MMP-12 pathway in macrophages.
    Zheng L; Xing L; Zeng C; Wu T; Gui Y; Li W; Lan T; Yang Y; Gu Q; Qi C; Zhang Q; Tang F; He X; Wang L
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):368-77. PubMed ID: 25503990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PI3K p110δ regulates expression of CD38 on regulatory T cells.
    Patton DT; Wilson MD; Rowan WC; Soond DR; Okkenhaug K
    PLoS One; 2011 Mar; 6(3):e17359. PubMed ID: 21390257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.
    Maharaj K; Powers JJ; Achille A; Mediavilla-Varela M; Gamal W; Burger KL; Fonseca R; Jiang K; Miskin HP; Maryanski D; Monastyrskyi A; Duckett DR; Roush WR; Cleveland JL; Sahakian E; Pinilla-Ibarz J
    Blood Adv; 2020 Jul; 4(13):3072-3084. PubMed ID: 32634240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.